Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases

被引:59
|
作者
Calingasan, N. Y. [1 ]
Ho, D. J. [1 ]
Wille, E. J. [1 ]
Campagna, M. V. [1 ]
Ruan, J. [1 ]
Dumont, M. [1 ]
Yang, L. [1 ]
Shi, Q. [2 ]
Gibson, G. E. [2 ]
Beal, M. F. [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA
[2] Cornell Univ, Burke Med Res Inst, Dept Neurol & Neurosci, Weill Med Coll, White Plains, NY 10605 USA
关键词
mitochondrial enzyme; neurogenesis; neuroblasts; doublecortin; polysialic acid-neural cell adhesion molecule; lipid peroxidation; subgranular zone;
D O I
10.1016/j.neuroscience.2008.02.071
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mitochondrial defects including reduction of a key mitochondrial tricarboxylic acid cycle enzyme alpha-ketoglutarate-dehydrogenase complex (KGDHC) are characteristic of many neurodegenerative diseases. KGDHC consists of alpha-ketoglutarate dehydrogenase, dihydrolipoyl succinyltransferase (E2k), and dihydrolipoamide dehydrogenase (Did) subunits. We investigated whether Did or E2k deficiency influences adult brain neurogenesis using immunohistochemistry for the immature neuron markers, doublecortin (Dcx) and polysialic acid-neural cell adhesion molecule, as well as a marker for proliferation, proliferating cell nuclear antigen (PCNA). Both Dld- and E2k-deficient mice showed reduced Dcx-positive neuroblasts in the subgranular zone (SGZ) of the hippocampal dentate gyrus compared with wild-type mice. In the E2k knockout mice, increased immunoreactivity for the lipid peroxidation marker, malondialdehyde occurred in the SGZ. These alterations did not occur in the subventricular zone (SVZ). PCNA staining revealed decreased proliferation in the SGZ of E2k-deficient mice. In a transgenic mouse model of Alzheimer's disease, Dcx-positive cells in the SGZ were also reduced compared with wild type, but Did deficiency did not exacerbate the reduction. In the malonate lesion model of Huntington's disease, Did deficiency did not alter the lesion-induced increase and migration of Dcx-positive cells from the SVZ into the ipsilateral striatum. Thus, the KGDHC subunit deficiencies associated with elevated lipid peroxidation selectively reduced the number of neuroblasts and proliferating cells in the hippocampal neurogenic zone. However, these mitochondrial defects neither exacerbated certain pathological conditions, such as amyloid precursor protein (APP) mutation-induced reduction of SGZ neuroblasts, nor inhibited malonate-induced migration of SVZ neuroblasts. Our findings support the view that mitochondrial dysfunction can influence the number of neural progenitor cells in the hippocampus of adult mice. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:986 / 996
页数:11
相关论文
共 50 条
  • [21] Transgenic Mouse Models for the Study of Neurodegenerative Diseases
    Marin-Moreno, Alba
    Canoyra, Sara
    Fernandez-Borges, Natalia
    Carlos Espinosa, Juan
    Maria Torres, Juan
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (01):
  • [22] Mitochondrial function and dynamics in neural stem cells and neurogenesis: Implications for neurodegenerative diseases
    Coelho, Patricia
    Fao, Ligia
    Mota, Sandra
    Rego, A. Cristina
    AGEING RESEARCH REVIEWS, 2022, 80
  • [23] Neurogenesis in the Diseased Adult Human Brain New Therapeutic Strategies for Neurodegenerative Diseases
    Curtis, Maurice A.
    Connor, Bronwen
    Faull, Richard L. M.
    CELL CYCLE, 2003, 2 (05) : 428 - 430
  • [24] Neurodegenerative diseases:: Insights from Drosophila and mouse models
    Botas, J
    NEUROSCIENCES IN THE POSTGENOMIC ERA, 2003, : 85 - 103
  • [25] Adult Hippocampal Neurogenesis, Aging and Neurodegenerative Diseases: Possible Strategies to Prevent Cognitive Impairment
    Vivar, Carmen
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (21) : 2175 - 2192
  • [26] Metabotropic receptors in transgenic mouse models of human neurodegenerative diseases
    Cha, JHJ
    Frey, AS
    Irizarry, MC
    Hyman, BT
    Young, AB
    Penney, JB
    NEUROPHARMACOLOGY, 1999, 38 (10) : A11 - A11
  • [27] Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases
    Bailey, CDC
    Graham, RM
    Nanda, N
    Davies, PJA
    Johnson, GV
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 25 (03) : 493 - 503
  • [28] Synaptic plasticity studies and their applicability in mouse models of neurodegenerative diseases
    Gruart, Agnes
    Madronal, Noelia
    Teresa Jurado-Parras, Maria
    Delgado-Garcia, Jose M.
    TRANSLATIONAL NEUROSCIENCE, 2013, 4 (02) : 134 - 143
  • [29] Neuroendocrinology of neurodegenerative diseases - Insights from transgenic mouse models
    de Aguilar, JLG
    René, F
    Dupuis, L
    Loeffler, JP
    NEUROENDOCRINOLOGY, 2003, 78 (05) : 244 - 252
  • [30] Targeting Mitochondrial Defects to Increase Longevity in Animal Models of Neurodegenerative Diseases
    Casajus Pelegay, Ester
    Puzzo, Francesco
    Yilmazer, Acelya
    Cagin, Umut
    REVIEWS ON BIOMARKER STUDIES OF METABOLIC AND METABOLISM-RELATED DISORDERS, 2019, 1134 : 89 - 110